Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.53 USD | +1.73% | -1.24% | -32.93% |
Business Summary
Number of employees: 1,259
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Consumables
77.5
%
| 436 | 84.3 % | 480 | 77.5 % | +10.09% |
Instruments
20.0
%
| 72 | 14.0 % | 123 | 20.0 % | +70.55% |
Services
2.5
%
| 8 | 1.6 % | 16 | 2.5 % | +86.39% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
58.2
%
| 285 | 55.2 % | 360 | 58.2 % | +26.35% |
Europe, Middle East and Africa
23.0
%
| 117 | 22.7 % | 142 | 23.0 % | +21.53% |
Asia Pacific (excluding China)
8.5
%
| 46 | 8.9 % | 52 | 8.5 % | +13.67% |
China
8.2
%
| 60 | 11.5 % | 51 | 8.2 % | -14.43% |
Americas (excluding United States)
2.1
%
| 9 | 1.7 % | 13 | 2.1 % | +49.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Serge Saxonov
FOU | Founder | 47 | 12-07-01 |
Ben Hindson
FOU | Founder | 49 | 12-07-01 |
Justin McAnear
DFI | Director of Finance/CFO | 49 | 18-09-30 |
Chief Tech/Sci/R&D Officer | - | 12-12-31 | |
Rebecca Port
HRO | Human Resources Officer | - | 20-12-31 |
General Counsel | 56 | 17-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Stuelpnagel
CHM | Chairman | 66 | 13-07-31 |
Kim Popovits
BRD | Director/Board Member | 65 | 20-03-25 |
Mathai Mammen
BRD | Director/Board Member | 57 | 17-08-22 |
Ben Hindson
FOU | Founder | 49 | 12-07-01 |
Serge Saxonov
FOU | Founder | 47 | 12-07-01 |
Sridhar Kosaraju
BRD | Director/Board Member | 46 | 19-02-28 |
Shehnaaz Suliman
BRD | Director/Board Member | 52 | 19-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 14,056,833 | 0 | 0 | 84.78 % |
Stock B | 1 | 105,109,711 | 101,031,768 ( 96.12 %) | 0 |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.93% | 4.47B | |
+1.64% | 13.05B | |
-13.95% | 7.32B | |
-4.01% | 5.15B | |
-0.04% | 4.58B | |
+0.39% | 4.27B | |
+16.88% | 2.85B | |
+3.24% | 2.55B | |
+11.39% | 1.92B | |
+1.28% | 1.7B |
- Stock
- Equities
- Stock 10x Genomics, Inc. - Nasdaq
- Company 10x Genomics, Inc.